Margaritis News
-
2024
Apr / 24- GeneVentiv Obtains $2.5 Million SBIR Grant to Develop Hemophilia Gene Therapy
- Apr 24, 2024 at 08:00 pm
- GeneVentiv Therapeutics has received a $2.5 million grant to conduct preclinical tests on its one-time infusion gene therapy for hemophilia A and B, with or without clotting factor inhibitors. The therapy, GENV-HEM, will be tested in a large study with a canine model of hemophilia, following promising results in mouse models of both hemophilia types. Funds will also be used to evaluate the gene therapy's distribution in the body and associated toxicology. These studies are expected to support a future investigational new drug application for the therapy.
-
- {{val.name}}
- {{val.createtime}}
- {{val.seo_description}}
Communtity feeds
-
- Twitter source
- Ash Crypto Feb 24, 2025 at 08:24 pm
-
- Twitter source
- Ash Crypto Feb 24, 2025 at 08:05 pm
-
- Twitter source
- Cointelegraph Feb 24, 2025 at 07:39 pm
-
- Twitter source
- Cointelegraph Feb 24, 2025 at 07:13 pm
-
- Twitter source
- Mario Nawfal’s Roundtable Feb 24, 2025 at 06:33 pm
-
- Twitter source
- Master of Crypto Feb 24, 2025 at 06:22 pm
-
- Twitter source
- 𝑴𝒓. 𝑩𝒊𝒍𝒍𝒊𝒐𝒏𝒂𝒊𝒓𝒆💰 Feb 24, 2025 at 05:23 pm
JUST IN: TG Boss, Durov has completed the deletion of all Channels that their Projects ain't under the $TON Blockchain. -
- Twitter source
- Cointelegraph Feb 24, 2025 at 05:03 pm
-
- Twitter source
- {{val.author }} {{val.createtime }}